The application of conductivity measurements to evaluate commercial digoxin tablet formulations
Rubinstein, M.H.; Wells, J.I.
Pharmaceutica Acta Helvetiae 52(5): 112-115
1977
ISSN/ISBN: 0031-6865 PMID: 928471 Document Number: 115882
Document emailed within 1 workday
Related Documents
Li, X.-h.; Li, M.-d.; Du, Y.; Zhao, L.-j.; Feng, Y.; Xu, D.-s.; Ruan, K.-f. 2013: Application of factor analysis to evaluate deformation behaviors of frequently-used tablet excipients Yao Xue Xue Bao 48(9): 1475-1483Yang, J.Y.; Wu, Q. 1988: Application of dynamic programming for quantitative analysis of qutong tablet and keganmin tablet Yao Xue Xue Bao 23(10): 756-761
Dobrev, D.; Berndt, A.; Oertel, R.; Richter, K.; Terhaag, B.; Gramatté, T. 1995: The bioequivalence of metoclopramide in two tablet formulations Arzneimittel-Forschung 45(3): 304-306
Harahap, Y.; Prasaja, B.; Indriati, E.; Lusthom, W.; Lipin 2007: Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers International Journal of Clinical Pharmacology and Therapeutics 45(6): 373-376
Gatti, R.; Cavrini, V.; Balboni, B.; Roveri, P. 1985: Colorimetric assay for methimazole in tablet formulations using the 2,6-dichloroquinone chloroimide reagent Il Farmaco; Edizione Pratica 40(3): 71-76
Vio, L.; Mamolo, M.G.; Furlan, G. 1988: Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC Il Farmaco; Edizione Pratica 43(5): 157-164
Richter, H.G.; Schuchardt, W. 1981: Heat conductivity measurements on different tissues and their significance for laser surgery of the larynx Hno 29(5): 163-164
Uslu, B.; Demircigil, B.T.; Ozkan, S.A.; Sentürk, Z.; Aboul-Enein, H.Y. 2001: Simultaneous determination of melatonin and pyridoxine in tablet formulations by differential pulse voltammetry Die Pharmazie 56(12): 938-942
Kaeser, B.; Charoin, J.E.; Gerber, M.; Oxley, P.; Birnboeck, H.; Saiedabadi, N.; Banken, L. 2005: Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects International Journal of Clinical Pharmacology and Therapeutics 43(3): 154-162
Balaji, S.; Sunitha, A. 2010: Development and validation of spectrophotometeric method for simultaneous determination of simvastatin and ezetimibe in tablet formulations Pakistan Journal of Pharmaceutical Sciences 23(4): 375-378
Liu, Y.; Yi, T.; Huan, D.; Xiao, L.; He, J.-k. 2010: Use of an in vitro lipolysis model to evaluate type i lipid formulations Yao Xue Xue Bao 45(10): 1307-1311
Chukwu, K.I.; Udeala, O.K. 2000: Binding effectiveness of Colocassia esculenta gum in poorly compressible drugs-paracetamol and metronidazole tablet formulations Bollettino Chimico Farmaceutico 139(2): 89-97
Bagenda, A.; Barlow-Mosha, L.; Bagenda, D.; Sakwa, R.; Fowler, M.G.; Musoke, P.M. 2011: Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda Annals of Tropical Paediatrics 31(3): 235-245
Rojanasthien, N.; Nasangiam, N.; Kumsorn, B.; Roongapinun, S.; Jengjareon, A. 2008: Pharmacokinetics and bioequivalence study of the two 20-mg quinapril hydrochloride tablet formulations in healthy Thai male volunteers Journal of the Medical Association of Thailand 91(5): 739-746
Zhu, C.J.; Wu, J.F.; Qu, Z.W.; Chen, L.M.; Zhang, J.T. 1999: Bioequivalence evaluation of two sertraline tablet formulations in healthy male volunteers after a single dose administration International Journal of Clinical Pharmacology and Therapeutics 37(3): 120-124
Yildirim, A.; Güneş, V.; Iça, A.; Sariözkan, S.ş; Düzlü, O.; Inci, A.; Albasan, H. 2008: The investigation of short term efficiency of oxfendazole + oxyclozanide paste and tablet formulations against gastrointestinal nematodes in sheep Turkiye Parazitolojii Dergisi 32(2): 134-138
Oge, E.K.; Polonus, P.A. 1978: Cross reactivity of dihydrodigoxin with a commercial digoxin kit Clinical Chemistry 24(6): 1086
Annunziato, L.; di Renzo, G. 1993: A bioequivalence study of tablet and powder formulations of the nonsteroidal anti-inflammatory drug 2-methoxyphenyl 1-methyl-5-(p-methylbenzoylpyrrol)-2-acetamidoacetate La Clinica Terapeutica 142(1 Part 2): 11-17
Hagemann, P. 1978: In vitro active ingredient liberation of five commercial prednisolone preparations in tablet form Pharmaceutica Acta Helvetiae 53(5): 133-135
Nykänen, P.; Sten, T.; Jürjenson, H.; Veski, P.; Marvola, M. 2004: Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery Die Pharmazie 59(4): 268-273